| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0...
Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0...
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and raises the price tar...
Roth Capital analyst Darren Aftahi upgrades Core Scientific (NASDAQ:CORZ) from Neutral to Buy and raises the price target fr...
Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shar...
ISS Highlights Numerous Concerns Regarding the Sale Process, Deal Structure and ValuationAgrees with Two Seas That the Board...
https://www.bloomberg.com/news/articles/2025-10-21/coreweave-won-t-raise-bid-for-core-scientific-ceo-intrator-says?srnd=homepag...